These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 2139026

  • 1. A comparative examination of a role for serotonin in obsessive compulsive disorder, panic disorder, and anxiety.
    Murphy DL, Pigott TA.
    J Clin Psychiatry; 1990 Apr; 51 Suppl():53-8; discussion 59-60. PubMed ID: 2139026
    [Abstract] [Full Text] [Related]

  • 2. Obsessive-compulsive disorder as a 5-HT subsystem-related behavioural disorder.
    Murphy DL, Zohar J, Benkelfat C, Pato MT, Pigott TA, Insel TR.
    Br J Psychiatry Suppl; 1989 Dec; (8):15-24. PubMed ID: 2692636
    [Abstract] [Full Text] [Related]

  • 3. Obsessive-compulsive disorder: treatment with serotonin-selective uptake inhibitors, azapirones, and other agents.
    Murphy DL, Pato MT, Pigott TA.
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):91S-100S. PubMed ID: 1973944
    [Abstract] [Full Text] [Related]

  • 4. Panic disorder: the potential role of serotonin reuptake inhibitors.
    Sheehan DV, Zak JP, Miller JA, Fanous BS.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():30-6. PubMed ID: 3045109
    [Abstract] [Full Text] [Related]

  • 5. The serotonin hypothesis of obsessive compulsive disorder: implications of pharmacologic challenge studies.
    Barr LC, Goodman WK, Price LH, McDougle CJ, Charney DS.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():17-28. PubMed ID: 1532961
    [Abstract] [Full Text] [Related]

  • 6. The potential role of serotonin reuptake inhibitors in the treatment of obsessive compulsive disorder.
    Zak JP, Miller JA, Sheehan DV, Fanous BS.
    J Clin Psychiatry; 1988 Aug; 49 Suppl():23-9. PubMed ID: 3045108
    [Abstract] [Full Text] [Related]

  • 7. Pharmacotherapy of obsessive compulsive disorder.
    Goodman WK, McDougle CJ, Price LH.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():29-37. PubMed ID: 1532962
    [Abstract] [Full Text] [Related]

  • 8. Neurobiology of obsessive compulsive disorder: a possible role for serotonin.
    Winslow JT, Insel TR.
    J Clin Psychiatry; 1990 Aug; 51 Suppl():27-31; discussion 55-8. PubMed ID: 2199432
    [Abstract] [Full Text] [Related]

  • 9. The antidepressant effects of 5-HT uptake inhibitors.
    Aberg-Wistedt A.
    Br J Psychiatry Suppl; 1989 Dec; (8):32-40. PubMed ID: 2692638
    [Abstract] [Full Text] [Related]

  • 10. An integrated approach to treatment of obsessive compulsive disorder.
    Greist JH.
    J Clin Psychiatry; 1992 Apr; 53 Suppl():38-41. PubMed ID: 1532963
    [Abstract] [Full Text] [Related]

  • 11. [Obsessive-compulsive symptoms associated with panic disorder. Predictive factor of a good therapeutic response to fluvoxamine].
    Servant D, Bailly D, Le Seac'h H, Parquet PJ.
    Encephale; 1990 Apr; 16 Spec No():359-62. PubMed ID: 2120029
    [Abstract] [Full Text] [Related]

  • 12. Animal models of obsessive-compulsive disorder: rationale to understanding psychobiology and pharmacology.
    Korff S, Harvey BH.
    Psychiatr Clin North Am; 2006 Jun; 29(2):371-90. PubMed ID: 16650714
    [Abstract] [Full Text] [Related]

  • 13. Pharmacologic treatment of anxiety disorders.
    Mavissakalian M.
    J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
    [Abstract] [Full Text] [Related]

  • 14. Clonazepam in the treatment of obsessive compulsive disorder associated with panic disorder in one patient.
    Bodkin JA, White K.
    J Clin Psychiatry; 1989 Jul; 50(7):265-6. PubMed ID: 2738031
    [Abstract] [Full Text] [Related]

  • 15. Treatment of depersonalization with serotonin reuptake blockers.
    Hollander E, Liebowitz MR, DeCaria C, Fairbanks J, Fallon B, Klein DF.
    J Clin Psychopharmacol; 1990 Jun; 10(3):200-3. PubMed ID: 2115893
    [Abstract] [Full Text] [Related]

  • 16. Treating the anxiety: therapeutic options in obsessive compulsive disorder.
    Greist JH.
    J Clin Psychiatry; 1990 Nov; 51 Suppl():29-34. PubMed ID: 2146255
    [Abstract] [Full Text] [Related]

  • 17. The pharmacologic treatment of anxiety disorders: a review of progress.
    Ravindran LN, Stein MB.
    J Clin Psychiatry; 2010 Jul; 71(7):839-54. PubMed ID: 20667290
    [Abstract] [Full Text] [Related]

  • 18. [Biological treatments in obsessive-compulsive disorder].
    Montgomery SA, Fineberg NA, Montgomery D.
    Encephale; 1990 Jul; 16 Spec No():335-9. PubMed ID: 2209492
    [Abstract] [Full Text] [Related]

  • 19. Monoamine receptor systems and anxiety disorders.
    Heninger GR, Charney DS.
    Psychiatr Clin North Am; 1988 Jun; 11(2):309-26. PubMed ID: 2843838
    [Abstract] [Full Text] [Related]

  • 20. The psychopharmacology of obsessive compulsive disorder. Implications for treatment and pathogenesis.
    McDougle CJ, Goodman WK, Leckman JF, Price LH.
    Psychiatr Clin North Am; 1993 Dec; 16(4):749-66. PubMed ID: 8309811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.